Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland

Safraj Shahul Hameed; Chris Robertson; Kirsty Morrison; Ross McQueenie; Jim McMenamin; Sam Ghebrehewet; Kimberly Marsh

doi:10.1016/S1473-3099(25)00064-7

Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland

Safraj Shahul Hameed, Chris Robertson, Kirsty Morrison, Ross McQueenie, Jim McMenamin, Sam Ghebrehewet, Kimberly Marsh

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	256-258
Number of pages	3
Journal	Lancet Infectious Diseases
Volume	25
Issue number	3
Early online date	13 Feb 2025
DOIs	https://doi.org/10.1016/S1473-3099(25)00064-7
Publication status	Published - Mar 2025

Keywords

Respiratory syncytial virus
vaccines
older population
Scotland

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1473-3099(25)00064-7

Cite this

@article{877b8e5a82034d89bd224c28b37ff3b2,

title = "Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland",

keywords = "Respiratory syncytial virus, vaccines, older population, Scotland",

author = "Hameed, {Safraj Shahul} and Chris Robertson and Kirsty Morrison and Ross McQueenie and Jim McMenamin and Sam Ghebrehewet and Kimberly Marsh",

year = "2025",

month = mar,

doi = "10.1016/S1473-3099(25)00064-7",

language = "English",

volume = "25",

pages = "256--258",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Limited",

number = "3",

}

TY - JOUR

T1 - Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland

AU - Hameed, Safraj Shahul

AU - Robertson, Chris

AU - Morrison, Kirsty

AU - McQueenie, Ross

AU - McMenamin, Jim

AU - Ghebrehewet, Sam

AU - Marsh, Kimberly

PY - 2025/3

Y1 - 2025/3

KW - Respiratory syncytial virus

KW - vaccines

KW - older population

KW - Scotland

U2 - 10.1016/S1473-3099(25)00064-7

DO - 10.1016/S1473-3099(25)00064-7

M3 - Comment/debate

C2 - 39956120

SN - 1473-3099

VL - 25

SP - 256

EP - 258

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 3

ER -